ASIT K JHA MD NPI 1497745632

NPI Details

Asit K Jha, MD is a medical oncology internal medicine in Waycross, GA with 30 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Asit K Jha, MD NPI is 1497745632. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1206 ALICE ST
WAYCROSS, GA
ZIP 31501-525
Phone: (912) 285-1140
Fax: (912) 285-1125

The NPI 1497745632 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more (HCPCS:99213)
• Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more (HCPCS:99214)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg (HCPCS:Q5130)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services (HCPCS:M0010)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's (HCPCS:G2211)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more (HCPCS:99204)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Red blood count, automated test (HCPCS:85045)
• Unclassified drugs (HCPCS:J3490)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes (HCPCS:99222)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more (HCPCS:99215)
• New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more (HCPCS:99205)
• Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (HCPCS:99232)
• Urinalysis, manual test (HCPCS:81002)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)

The enumeration date for this NPI number is 10/27/2005 and was last updated on 12/29/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.